Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept

BACKGROUND: Two randomized phase III trials (EORTC55971 and CHORUS) showed similar progression-free and overall survival in primary or interval debulking surgery in ovarian cancer, however both studies had limitations with lower rate of complete resection and lack of surgical qualifications for part...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Gynecol Oncol
Hlavní autoři: Jiang, Rong, Zhu, Jianqing, Kim, Jae-Weon, Liu, Jihong, Kato, Kazuyoshi, Kim, Hee-Seung, Zhang, Yuqin, Zhang, Ping, Zhu, Tao, Aoki, Daisuke, Yu, Aijun, Chen, Xiaojun, Wang, Xipeng, Zhu, Ding, Zhang, Wei, Jia, Huixun, Shi, Tingyan, Gao, Wen, Yin, Sheng, Feng, Yanling, Xiang, Libing, Okamoto, Aikou, Zang, Rongyu
Médium: Artigo
Jazyk:Inglês
Vydáno: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2020
Témata:
Clinical Trial Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7440987/
https://ncbi.nlm.nih.gov/pubmed/32808504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2020.31.e86
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky